Trial Condition(s):

Contraception, Heavy Menstrual Bleeding (HMB)

DUB/OC: QT prolongation

Bayer Identifier:

91516

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2006-004966-14

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
53
Trial Dates
black-arrow
Phase
1
Could I receive a placebo?
No
Products
Natazia/Qlaira (EV/DNG, BAY86-5027)
Accepts Healthy Volunteers
N/A

Where to Participate

Loading...
Locations
Locations
Locations

Bayer Pharma AG

Berlin, Germany, 13353

For details, please refer to trial results

Additional Information